Eris Lifesciences fundamental analysis
ERIS
1385
42.80 (3.19%)Last updated on 1 Feb, 2026 | 15:29 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Eris Lifesciences Fundamentals
P/E Ratio
45.78
P/B Ratio
5.41
Div. Yield
0.54
Sector P/E
65.25
Sector P/B
1.2
Sec. Div. Yield
0.58
Eris Lifesciences Fundamentals is currently trading with a P/E Ratio of 45.78, compared to the sector average of 65.25. Its P/B Ratio stands at 5.41, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0.54%, which is than the sector’s 0.58%.
Eris Lifesciences Score Card
Price
Expensive
Growth
Poor
Quality
Good
Management
Good
On its scorecard, Eris Lifesciences reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
